Since there were a cross-talk between EGFR and IGF-1R pathways and the cross-talk may be one of reasons for the resistance of cancer cells to drug and radiotherapy [16,17], co-inhibition of both pathways have been investigated and found out that it could synergistically inhibit tumor proliferation and growth [7,15]. The gene discussed is IGF1R; the disease is neoplasm.